TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. March 30, 2001
